华领医药组建销售团队。2025年开年,华领医药(02552.HK)组建销售团队有了新进展。1月1日,华领医药对外宣布,任命拥有20多年跨国药企工作经验,以及近20年糖尿病药品和市场领域工作经验的陆宇为公司销售与市场事业部副总裁。陆宇将带领新组建的销售与市场事业部,全面负责华领医药核心产品多格列艾汀(商品名:华堂宁)的销售和推广。与此同时,华领医药与拜耳医药保健有限公司(下称“拜耳”)正式结束华堂宁...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.